[{"AccountsPayableCurrent_0_Q1_USD":18184000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":271000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":570000.0,"CommonStockValueOutstanding_0_Q1_USD":1656000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":2000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-2354000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":334025000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-597000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":3532000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":8601000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":2.24,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":3530000.0,"OtherAssetsNoncurrent_0_Q1_USD":1513000.0,"LongTermDebtNoncurrent_0_Q1_USD":40521000.0,"Goodwill_0_Q1_USD":1095000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":15047000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1131000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":2.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":2.41,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":10255000.0,"InventoryValuationReserves_0_Q1_USD":350000.0,"ShortTermInvestments_0_Q1_USD":16503000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":9929000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1_Q1_USD":6000000.0,"PreferredStockValueOutstanding_0_Q1_USD":null,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":597000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":144000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":2000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5193000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5224000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1286000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":8383000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":325000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1051000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":2048000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":10613000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":33814000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1978000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":25200000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":448000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":310000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":1694000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":13740000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":33079000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":76000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":10309000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-326000.0,"LiabilitiesCurrent_0_Q1_USD":37261000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":136804000.0,"Liabilities_0_Q1_USD":83006000.0,"InventoryNet_0_Q1_USD":17309000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":154000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3663000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":5479000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":5359000.0,"GrossProfit_1_Q1_USD":18032000.0,"CommonStockSharesOutstanding_0_Q1_shares":165560000.0,"CommonStockSharesIssued_0_Q1_shares":165560000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":33814000.0,"AssetsCurrent_0_Q1_USD":112332000.0,"Assets_0_Q1_USD":136804000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":16320000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-700000.0,"AccountsReceivableNetCurrent_0_Q1_USD":31412000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.01,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":5580000.0,"NetIncomeLoss_1_Q1_USD":-2356000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":641000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":271000.0,"ShareBasedCompensation_1_Q1_USD":1978000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":16422000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2981000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":3000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"OperatingIncomeLoss_1_Q1_USD":-1371000.0,"InterestPaidNet_1_Q1_USD":935000.0,"InterestExpense_1_Q1_USD":1061000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"AccruedLiabilitiesCurrent_0_Q1_USD":15743000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":165429000.0,"StockholdersEquity_0_Q1_USD":53798000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-281183000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":16223000.0,"ProfitLoss_1_Q1_USD":-2356000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3365000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1309000.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_1_Q1_shares":170000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]